Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-001708
Filing Date
2023-02-02
Accepted
2023-02-02 16:30:27
Documents
3
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_q2_financial_results.htm 6-K 42173
2 EX-99.1 vrax-ex99_1.htm EX-99.1 1041090
3 EX-99.2 vrax-ex99_2.htm EX-99.2 79339
  Complete submission text file 0000950170-23-001708.txt   1163635
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 23581329
SIC: 2835 In Vitro & In Vivo Diagnostic Substances